APOE and Alzheimer disease: ARIA-E and ARIA-H occur in the natural history of AD, as demonstrated by non-zero rates in the placebo group and are associated with the presence of CAA and ApoE e4 genotype status, with risks increased by anti-amyloid therapies [18].